Mucosal expression profiling in patients with inflammatory bowel disease before and after first infliximab treatment

We used microarrays to identify mucosal gene signatures predictive of response to infliximab (IFX) in patients with inflammatory bowel disease (IBD) and to gain more insight into the pathogenesis of IBD.

keywords: drug response and treatment effect expression profiling by array